BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7672685)

  • 21. Reduced bone density in patients with inflammatory bowel disease.
    Bjarnason I; Macpherson A; Mackintosh C; Buxton-Thomas M; Forgacs I; Moniz C
    Gut; 1997 Feb; 40(2):228-33. PubMed ID: 9071937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone loss in patients with inflammatory bowel disease: a prospective study.
    Roux C; Abitbol V; Chaussade S; Kolta S; Guillemant S; Dougados M; Amor B; Couturier D
    Osteoporos Int; 1995 May; 5(3):156-60. PubMed ID: 7655175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled corticosteroid use and bone-mineral density in patients with asthma.
    Wong CA; Walsh LJ; Smith CJ; Wisniewski AF; Lewis SA; Hubbard R; Cawte S; Green DJ; Pringle M; Tattersfield AE
    Lancet; 2000 Apr; 355(9213):1399-403. PubMed ID: 10791523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
    Tobias JH; Sasi MR; Greenwood R; Probert CS
    Aliment Pharmacol Ther; 2004 Nov; 20(9):951-7. PubMed ID: 15521842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease.
    Robinson RJ; al-Azzawi F; Iqbal SJ; Abrams K; Mayberry JF
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):945-9. PubMed ID: 9391782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
    Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
    Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic bone assessment in patients with inflammatory bowel disease.
    Abitbol V; Roux C; Chaussade S; Guillemant S; Kolta S; Dougados M; Couturier D; Amor B
    Gastroenterology; 1995 Feb; 108(2):417-22. PubMed ID: 7835582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease.
    Turk N; Kastelan D; Cukovic-Cavka S; Kraljevic I; Korsic M; Vucelic B
    Ultrasound Med Biol; 2007 Jun; 33(6):863-9. PubMed ID: 17434664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density in patients with inflammatory bowel disease.
    Martin JP; Tonge KA; Bhonsle U; Jacyna MR; Levi J
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):537-41. PubMed ID: 10755258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
    Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
    World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis.
    Ghosh S; Cowen S; Hannan WJ; Ferguson A
    Gastroenterology; 1994 Oct; 107(4):1031-9. PubMed ID: 7926456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density assessment in children with inflammatory bowel disease.
    Gokhale R; Favus MJ; Karrison T; Sutton MM; Rich B; Kirschner BS
    Gastroenterology; 1998 May; 114(5):902-11. PubMed ID: 9558278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
    Kaya G; Koçak E; Akbal E; Taş A; Köklü S
    South Med J; 2011 Nov; 104(11):747-51. PubMed ID: 22024784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
    Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F
    Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body composition in patients with inflammatory bowel disease: a population-based study.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical markers and bone densitometry in inflammatory bowel disease.
    Ledro Cano D; Torres Domínguez Y; Castro Laria L; Sáenz Dana M; Herrerías Esteban JM; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2000 Sep; 92(9):595-600. PubMed ID: 11138241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.